Torrent Pharmaceuticals share price
Torrent Pharmaceuticals Ltd. · NSE: TORNTPHARM · Healthcare
Price, one year
Price range
- Open
- ₹4,637.90
- High
- ₹4,650.70
- Low
- ₹4,476.10
- Previous close
- ₹4,615.30
- Volume
- 3.3 L
- Market cap
- ₹1,72,094 Cr
Key statistics
Results to 30 Sep 2026 · Consolidated- P/E (TTM)
- 76.4
- Price to book
- 9.4
- Return on equity
- 11.6%
- EPS (TTM)
- ₹59.20
- Book value / share
- ₹483.03
- Debt to equity
- 0.76
- Revenue (TTM)
- ₹17,400 Cr
- Net profit (TTM)
- ₹2,124 Cr
- Sales growth, YoY
- +50.8%
- Profit growth, YoY
- −9.6%
- Operating margin
- 33.2%
- Net margin
- 12.2%
- Sales CAGR, 3 years
- +13.3%
- Profit CAGR, 3 years
- +20.2%
- Promoter holding
- 60.78%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Jun 2026 | Jul 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 68.31 | 60.78 | 60.78 |
| Foreign institutions | 15.44 | 17.97 | 17.22 |
| Domestic institutions | 9.83 | 12.87 | 13.46 |
| Mutual funds | 4.94 | 8.27 | 8.82 |
| Retail and others | 5.04 | 6.82 | 6.95 |
Futures and options
23 Oct 2026- Lot size
- 125
- Put-call ratio (OI)
- 0.49
- Max pain
- ₹4,600.00
- Highest call OI strike
- 5,000.00
- Highest put OI strike
- 4,700.00
- ATM implied volatility
- 28.3% IV rank 65
- Futures basis
- −0.69%
- Rollover
- 63.2%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 23 Oct | Short buildup | −2.54% | +2.65% |
| 22 Oct | Long buildup | +1.39% | +1.32% |
| 21 Oct | Long unwinding | −0.20% | −0.92% |
| 19 Oct | Short buildup | −0.45% | +1.15% |
| 16 Oct | Short buildup | −0.81% | +0.62% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Sep 2026) filed 23 Oct 2026. results: 23 Oct 2026.
- 16 Oct 2026 · ManagementResignation of Director/KMP/SMPTorrent Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP
- 16 Oct 2026 · ManagementChange in ManagementTorrent Pharmaceuticals Limited has informed the Exchange about change in Management - Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 Change in Senior...
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
| LupinLUPIN | ₹1,928.90 | +0.36% |
Frequently asked questions
What is the share price of Torrent Pharmaceuticals today?
Torrent Pharmaceuticals (NSE: TORNTPHARM) was at ₹4,524.40 on 23 Oct 2026, a change of −1.97% from the previous close.
What are the 52-week high and low of Torrent Pharmaceuticals?
Over the last 52 weeks Torrent Pharmaceuticals traded between ₹3,480.60 and ₹5,250.00 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Torrent Pharmaceuticals?
About ₹1,72,094 Cr at the latest price, with a P/E of 76.4, a price-to-book of 9.4, a return on equity of 11.6%. Ratios use the company's latest reported results.
Who owns Torrent Pharmaceuticals shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 60.78%, foreign institutions 17.22%, domestic institutions 13.46%.
Is Torrent Pharmaceuticals traded in futures and options?
Yes, TORNTPHARM is in NSE's futures and options segment. The lot size is 125 shares.
Which sector and indices does Torrent Pharmaceuticals belong to?
NSE classifies Torrent Pharmaceuticals under Healthcare; it is a member of Nifty 100, Nifty 500.
Follow Torrent Pharmaceuticals with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial